본문 바로가기
KERD
논문KCI 등재

Extracellular vesicle-mediated transfer of miRNA-1 from primary tumors represses the growth of distant metastases

Cho Je-Yoel|Son Keun Hong|Kim Chae-Yi|Lee Kang-Hoon|Shin Tae-Jin
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2024.12|Experimental and Molecular Medicine|제56권 |pp. 734-746|DOI 10.1038/s12276-024-01181-7

0

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Metastases originate from primary tumors and reach distant organs. Growing evidence suggests that metastases are under the control of primary tumors even outside the primary site; however, the mechanisms by which primary tumors remotely control metastases remain unclear. Here, we discovered a molecular mechanism by which primary tumors suppress metastatic growth. Interestingly, we found that extracellular vesicles (EVs) derived from the primary tumor can inhibit the growth of metastases both in vitro and in vivo. miR-1 was particularly enriched in primary tumor-derived EVs (pTDEs) and was found to be responsible for the suppression of metastatic growth. Mechanistically, intracellular reactive oxygen species (ROS) production and DNA damage were induced, which led to cell cycle arrest. Collectively, our data demonstrate that primary tumors restrict the growth of distant metastases via miR-1 in pTDEs and that miR-1 could potentially be used as an antimetastatic agent.

Abstract

Metastases originate from primary tumors and reach distant organs. Growing evidence suggests that metastases are under the control of primary tumors even outside the primary site; however, the mechanisms by which primary tumors remotely control metastases remain unclear. Here, we discovered a molecular mechanism by which primary tumors suppress metastatic growth. Interestingly, we found that extracellular vesicles (EVs) derived from the primary tumor can inhibit the growth of metastases both in vitro and in vivo. miR-1 was particularly enriched in primary tumor-derived EVs (pTDEs) and was found to be responsible for the suppression of metastatic growth. Mechanistically, intracellular reactive oxygen species (ROS) production and DNA damage were induced, which led to cell cycle arrest. Collectively, our data demonstrate that primary tumors restrict the growth of distant metastases via miR-1 in pTDEs and that miR-1 could potentially be used as an antimetastatic agent.

참고문헌 (51)

  1. Riggio, A. I., "The lingering mysteries of metastatic recurrence in breast cancer", Br. J. Cancer, 124, pp.13~26 (2021)
  2. Giancotti, F. G., "Mechanisms governing metastatic dormancy and reactivation", Cell, 155, pp.750~764 (2013)
  3. Park, S.-Y., "The force awakens: metastatic dormant cancer cells", Exp. Mol. Med, 52, pp.569~581 (2020)
  4. Borriello, L., "Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells", Nat. Commun, 13, pp.1~19 (2022)
  5. Ji, Q., "Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation", Nat. Com mun, 11, pp.1~18 (2020)
  6. Piranlioglu, R., "Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model", Nat. Commun, 10, pp.1~13 (2019)
  7. Phan, T. G., "The dormant cancer cell life cycle", Nat. Rev. Cancer, 20, pp.398~411 (2020)
  8. Gimbrone, M. A. Jr, "Tumor dormancy in vivo by prevention of neovascularization", J. Exp. Med, 136, pp.261~276 (1972)
  9. Neophytou, C. M., "Mechanisms of metastatic tumor dormancy and implications for cancer therapy", Int. J. Mol. Sci, 20, pp.6158~ (2019)
  10. O’Reilly, M. S., "Angiostatin : a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma", Cell, 79, pp.315~328 (1994)
  11. O’Reilly, M. S., "Endostatin : an endogenous inhibitor of angiogenesis and tumor growth", Cell, 88, pp.277~285 (1997)
  12. Willimsky, G., "Sporadic immunogenic tumours avoid destruc tion by inducing T-cell tolerance", Nature, 437, pp.141~146 (2005)
  13. Théry, C., "Exosomes : composition, biogenesis and function", Nat. Rev. Immun, 2, pp.569~579 (2002)
  14. Tan, Y., "Tumor-derived exosomal components : the multifaceted roles and mechanisms in breast cancer metastasis", Cell Death Dis, 12, pp.1~18 (2021)
  15. Syn, N., "Exosome-mediated metastasis:from epithelial–mesenchymal transition to escape from immunosurveillance", Trends Pharmacol. Sci, 37, pp.606~617 (2016)
  16. Tian, W., "Potential role of exosomes in cancer metastasis", BioMed Res. Int, 2019, pp.4649705~ (2019)
  17. Fu, Q., "Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer", Oncogene, 37, pp.6105~6118 (2018)
  18. Ono, M., "Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells", Sci. Signal, 7, pp.ra63~ra63 (2014)
  19. Murai, K., "Establishment of a pair of novel cloned tumour cell lines with or without metastatic potential from canine mammary adenocarcinoma", Res. Veterinary Sci, 93, pp.468~472 (2012)
  20. Zhang, D., "Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo", Am. J. Physiology-Lung Cell. Mol. Physiol, 312, pp.L110~L121 (2017)
  21. Abdelmegeed, S. M., "Canine mammary tumors as a model for human disease", Oncol. Lett, 15, pp.8195~8205 (2018)
  22. Kim, T. -M., "Cross-species oncogenic signatures of breast cancer in canine mammary tumors", Nat. Commun, 11, pp.1~13 (2020)
  23. Li, R., "Distinct effects of general anesthetics on lung metastasis mediated by IL-6", JAK, Nat. Commun, pp.2020, 11[DOI]
  24. Duyverman, A. M., "Studying primary tumor–associated fibroblast involvement in cancer metastasis in mice", Nat. Protocols, 7, pp.756~762 (2012)
  25. Ben-Eliyahu, S., "Tumor excision as a metastatic Russian roulette : perioperative interventions to improve long-term survival of cancer patients", Trends Cancer, 6, pp.951~959 (2020)
  26. Kim, M. -Y., "Tumor self-seeding by circulating cancer cells", Cell, 139, pp.1315~1326 (2009)
  27. Stark, G. R., "Analyzing the G2", M checkpoint, 2004, pp.280, 51~82
  28. Dankert, J. F., "Cyclin F-mediated degradation of SLBP limits H2A. X accu mulation and apoptosis upon genotoxic stress in G2", Mol. Cell, 64, pp.507~519 (2016)
  29. Ayob, A. Z., "Cancer stem cells as key drivers of tumour pro gression", J. Biomed. Sci, 25, pp.1~18 (2018)
  30. Velasco-Velázquez, M. A., "The role of breast cancer stem cells in metastasis and therapeutic implications", Am. J. Pathol, 179, pp.2~11 (2011)
  31. Monteiro, J., "Cancer stemness and metastasis : therapeutic con sequences and perspectives", Eur. J. Cancer, 46, pp.1198~1203 (2010)
  32. Kuhn, N. Z., "Regulation of stemness and stem cell niche of mesenchymal stem cells : implications in tumorigenesis and metastasis", J. Cell. Physiol, 222, pp.268~277 (2010)
  33. Daugaard, M., "Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes", Nat. Commun, 4, pp.1~13 (2013)
  34. Mettouchi, A., "Ubiquitylation of active Rac1 by the E3 ubiquitin ligase HACE1", Small GTPases, 3, pp.102~106 (2012)
  35. Micalizzi, D. S., "A conduit to metastasis : circulating tumor cell biology", Genes Develop, 31, pp.1827~1840 (2017)
  36. Massagué, J., "Metastatic colonization by circulating tumour cells", Nature, 529, pp.298~306 (2016)
  37. Ganesh, K., "Targeting metastatic cancer", Nat. Med, 27, pp.34~44 (2021)
  38. Weiss, F., "Towards targeting of shared mechanisms of cancer metastasis and therapy resistance", Nat. Rev. Cancer, 22, pp.157~173 (2022)
  39. Chen, W., "Organotropism: new insights into mole cular mechanisms of breast cancer metastasis", NPJ Precision Oncol, 2, pp.1~12 (2018)
  40. Huang, Y., "Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis", Cancer Res, 69, pp.7529~7537 (2009)
  41. Rodrigues, G., "Tumour exosomal CEMIP protein promotes cancer cell colo nization in brain metastasis", Nat. Cell Biol, 21, pp.1403~1412 (2019)
  42. Ma, X., "Myeloid-derived suppressor cells promote metastasis in breast cancer after the stress of operative removal of the primary cancer", Front. Oncol, 9, pp.855~ (2019)
  43. Fidler, I. J., "The pathogenesis of cancer metastasis : the’seed and soil’hypothesis revisited", Nat. Rev. Cancer, 3, pp.453~458 (2003)
  44. Rashid, O. M., "Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden", Surgery, 153, pp.771~778 (2013)
  45. Dauplat, J., , Seminars in surgical oncology, pp.42~48, Wiley Online Library
  46. Colleoni, M., "Annual hazard rates of recurrence for breast cancer during 24years of follow-up : results from the international breast cancer study group trials I to V", J. Clin. Oncol, 34, pp.927~ (2016)
  47. Demicheli, R., "Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures", Nat. Clin. Pract. Oncol, 4, pp.699~710 (2007)
  48. Liu, C., "Tumor suppressor miR-1 inhibits tumor growth and metastasis by simultaneously targeting multiple genes", Oncotarget, 8, pp.42043~ (2017)
  49. Slater, C., "In vitro analysis of putative cancer stem cell populations and chemosensitivity in the SW480 and SW620 colon cancer metastasis model", Oncol. Lett, 15, pp.8516~8526 (2018)
  50. Xu, L., "Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K", AKT pathway, 2014, pp.12, 1~12
  51. Wang, Y., "Gene expression profile of cancer stem‑like cells in the SW480colon adenocarcinoma cell line", Oncol. Rep, 42, pp.386~398 (2019)

관련 논문AI추천

Emerging roles of exosomes in cancer invasion and metastasisHans Cao, Janet Lee, Jun Chung, Thalia Nguyen, Young Hwa Soung생화학분자생물학회 · BMB Reports2016 · 제49권 제1호Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancerChen Gang, Chen Zhuo-Kun, Duan Xu, Li Ye, Wang Kui-Ming, Xiao Bo-Lin, Zhang He-Jing생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancerHe Yan, Liu Qin-Wen, Xu Wen Wen생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancerChen Wenjie, Huang Jing, Lei Jianyong, Li Genpeng, Li Zhihui, Wang Xinyi생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 Extracellular vesicles as emerging intercellular communicasomes고용송, 김오연, 윤예진생화학분자생물학회 · BMB Reports2014 · 제47권 제10호Cancer-derived exosomal Alu RNA promotes colorectal cancer progressionAdinolfi Antonio, Ambati Jayakrishna, De Falco Sandro, D’Orsi Luca, Magliacane Trotta Sara, Mehlen Patrick, Mercadante Grazia, Panico Sonia, Tarallo Valeria생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권

이 간행물의 다른 논문 (218건)

Big data and deep learning for RNA biologyJeon Hyeonseong, Baek Daehyun, Hwang Hyeonseo, Yeo Nagyeongpp. 1-29RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinomaXu Yanan, Ke Shanjia, Lu Shounan, Bai Miaoyu, Yu Hongjun, Yin Bing, Wang Chaoqun, Feng Zhigang, Li Zihao, Huang Jingjing, Li Xinglong, Qian Baolin, Hua Yongliang, Fu Yao, Sun Bei, Wu Yaohua, Ma Yongpp. 1-14Molecular mechanisms of circular RNA translationKim Yoon Ki, Hwang Hyun Jungpp. 1-9The m6A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolismKim Ho, Yun Hye Jin, 이종호, Lee Su Bin, Kim Seok-Ho, Park Yun-Yong, Park Su Hwan, Ju Jin-Sung, Woo Hyunmin, Győrffy Balázs, Kim Eun-jeong, Han Hee Dong, Eyun Seong-ilpp. 1-15Neuron type-specific optogenetic stimulation for differential stroke recovery in chronic capsular infarctKim Ra Gyung, Cho Jongwook, Park Ji-Young, Kim Young Ro, Lee Min-Cheol, Kim Hyoung-Ihlpp. 1-11
원문 보기